Evidence map›Paper›PMID 35335412›Full record

ArticlePolymers2022

Novel Thymoquinone Nanoparticles Using Poly(ester amide) Based on L-Arginine-Targeting Pulmonary Drug Delivery.

Eman Zmaily Dahmash, Dalia Khalil Ali, Hamad S Alyami, Hussien AbdulKarim, Mohammad H Alyami, Alhassan H Aodah

Open access · goldAbstract read
In one paragraph

Article in Polymers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Analysis of Pharmacological Properties ofLife (Basel, Switzerland) · 2025
    Review
  3. Treatment of lung diseasesMaterials today. Bio · 2025
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Eman Zmaily DahmashDepartment of Applied Pharmaceutical Sciences and Clinical Pharmacy, Faculty of Pharmacy, Isra University, Amman 11622, Jordan.ORCID 0000-0002-9815-3720
Dalia Khalil AliDepartment of Physiotherapy, Faculty of Allied Medical Sciences, Isra University, Amman 11622, Jordan.ORCID 0000-0001-9680-0026
Hamad S AlyamiDepartment of Pharmaceutics, Faculty of Pharmacy, Najran University, Najran 55461, Saudi Arabia.ORCID 0000-0003-3513-4976
Hussien AbdulKarimDepartment of Applied Pharmaceutical Sciences and Clinical Pharmacy, Faculty of Pharmacy, Isra University, Amman 11622, Jordan.
Mohammad H AlyamiDepartment of Pharmaceutics, Faculty of Pharmacy, Najran University, Najran 55461, Saudi Arabia.ORCID 0000-0003-2731-1071
Alhassan H AodahNational Center of Biotechnology, Life Science & Environment Research Institute, King Abdulaziz City for Science and Technology, Riyadh 11442, Saudi Arabia.ORCID 0000-0001-5947-986X
Isra University · JONajran University · SAKing Abdulaziz City for Science and Technology · SA

Funding

Isra University (grant 50/3-2018/2019) and (grant 12-14/2020/2021).
6 · The paper itself

Abstract

Thymoquinone (

Indexed as

COVID-19L-argininenanoparticlespoly(ester amide)respiratory drug deliverythymoquinone

Identifiers

PMID35335412
PMCPMC8956027
OpenAlexW4220815490

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.